发明申请
US20070155690A1 RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis
审中-公开
RNAi介导的HIF1A抑制治疗眼血管发生
- 专利标题： RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis
- 专利标题（中）： RNAi介导的HIF1A抑制治疗眼血管发生
-
申请号： US11642016申请日： 2006-12-19
-
公开(公告)号： US20070155690A1公开(公告)日： 2007-07-05
- 发明人: Jon Chatterton , David Bingaman
- 申请人： Jon Chatterton , David Bingaman
- 申请人地址： US TX Fort Worth
- 专利权人： Alcon Manufacturing, Ltd.
- 当前专利权人： Alcon Manufacturing, Ltd.
- 当前专利权人地址： US TX Fort Worth
- 主分类号： A61K48/00
- IPC分类号： A61K48/00
摘要：
RNA interference, is provided for inhibition of HIF1A mRNA expression for treating patients with ocular angiogenesis, particularly for treating retinal edema, diabetic retinopathy, sequela associated with retinal ischemia, posterior segment neovascularization (PSNV), and neovascular glaucoma, and for treating patients at risk of developing such conditions.
公开/授权文献
- US1212098A Method of manufacturing articles of synthetic composition. 公开/授权日：1917-01-09